Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Holm

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Leukemia|May 13, 2014
Impact of chemotherapy delay on short- and long-term survival in younger and older AML patients: a Danish population-based cohort studyL S G Ostgard, J M Nørgaard, H Sengeløv, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 1, 1990
1,4-Dihydronaphthoquinones as water-soluble inhibitors of 5-lipoxygenaseR G Schaub, A Yamashita, M K Bach, et al.
Blood Cancer Journal|March 11, 2014
Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trialM Tobiasson, I Dybedahl, M S Holm, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Leukemia|May 13, 2014
Impact of chemotherapy delay on short- and long-term survival in younger and older AML patients: a Danish population-based cohort studyL S G Ostgard, J M Nørgaard, H Sengeløv, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 1, 1990
1,4-Dihydronaphthoquinones as water-soluble inhibitors of 5-lipoxygenaseR G Schaub, A Yamashita, M K Bach, et al.
Blood Cancer Journal|March 11, 2014
Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trialM Tobiasson, I Dybedahl, M S Holm, et al.
Pageof 2